Assessment of Gemcitabine as Chemoradiotherapy in Patients With Locally Advanced Carcinoma of Cervix and Renal Disease

Abroad (travel likely)RecruitingPHASE2

Conditions

Cervical Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

National Institute of Cancer, Mexico City, Mexico City, Mexico
Contact: Study coordinator (Lucely Cetina, MD, MSc) · micuentalucely@yahoo.com · +521555 4851237

Study leads

Lucely C Cetina, MD, M.Sc.
Principal Investigator
National Institute of Cancerología

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Diffuse Astrocytoma, IDH-Mutant · Glioblastoma, IDH-wildtype · Brain Metastases, Adult

Abroad (travel likely)RecruitingPHASE1, PHASE2

Beverly Hills, United States · Glendale, United States

A Phase 1/2 Trial of TER-2013 in Patients With Solid Tumors Harboring AKT/PI3K/PTEN Pathway Alterations

Breast Cancer · Endometrial Cancer · Ovarian Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Orlando, United States · Boston, United States

Hypofractionated Radiotherapy for the Treatment of Locally Advanced Cervical Cancer in Uganda

Cervical Cancer · Cervix Cancer · Cervical Adenocarcinoma

Abroad (travel likely)RecruitingPHASE2

Kampala, Uganda

Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer

Differentiated Thyroid Cancer · Pediatric Cancer · Cancer

Abroad (travel likely)RecruitingPHASE2

San Francisco, United States · Philadelphia, United States